Vivos Therapeutics, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO R. Kirk Huntsman, with a market cap of $9.0M.
Based on Q1 2026 filing
Common questions about Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. (VVOS) has a market capitalization of $9.0M and trades on NASDAQ.
Vivos Therapeutics, Inc. has approximately 114 employees.